| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $22.4M | -17.3% |
| Cost of Revenue | $9.7M | -29.6% |
| Gross Profit | $12.7M | -4.5% |
| R&D Expense | $13.8M | -43.0% |
| SG&A Expense | $15.2M | -25.8% |
| Operating Income | -$36.7M | +36.5% |
| Pre-tax Income | -$41.6M | +6.7% |
| Income Tax | $105K | +105.7% |
| Net Income | -$41.7M | +2.4% |
| EPS (Basic) | $10.12 | +1559.0% |
| EPS (Diluted) | $10.12 | +1559.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $21.8M | -21.5% |
| Accounts Receivable | $2.1M | -55.4% |
| Inventory | $4.3M | -9.2% |
| Current Assets | $35.1M | -13.5% |
| Total Assets | $110.1M | -7.4% |
| Current Liabilities | $9.3M | -44.0% |
| Long-term Debt | $30.7M | +31.0% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$25.9M | +32.7% |
| Capital Expenditures | $142K | +2.9% |
| Investing Cash Flow | -$4.3M | +51.4% |
| Financing Cash Flow | $24.3M | -36.9% |
| Free Cash Flow | -$26.1M | +32.6% |
| $67.9M |
| -5.7% |